Zhang P, Downey HF, Chen S, Shi X. Two-week normobaric intermittent hypoxia exposures enhance oxyhemoglobin equilibrium and cardiac responses during hypoxemia. Am J Physiol Regul Integr Comp Physiol 307: R721-R730, 2014. First published July 23, 2014 doi:10.1152/ajpregu.00191.2014 is extensively applied to challenge cardiovascular and respiratory function, and to induce physiological acclimatization. The purpose of this study was to test the hypothesis that oxyhemoglobin equilibrium and tachycardiac responses during hypoxemia were enhanced after 14-day IH exposures. Normobaric-poikilocapnic hypoxia was induced with inhalation of 10% O 2 for 5-6 min interspersed with 4 min recovery on eight nonsmokers. Heart rate (HR), arterial O 2 saturation (SaO2), and end-tidal O 2 (PETO2) were continuously monitored during cyclic normoxia and hypoxia. These variables were compared during the first and fifth hypoxic bouts between day 1 and day 14. There was a rightward shift in the oxyhemoglobin equilibrium response following 14-day IH exposures, as indicated by the greater PETO2 (an index of arterial PO2) at 50% of SaO2 on day 14 compared with day 1 [33.9 Ϯ 1.5 vs. 28.2 Ϯ 1.3 mmHg (P ϭ 0.005) during the first hypoxic bout and 39.4 Ϯ 2.4 vs. 31.4 Ϯ 1.5 mmHg (P ϭ 0.006) during the fifth hypoxic bout] and by the augmented gains of ⌬Sa O2/⌬PETO2 (i.e., deoxygenation) during PET O2 from 65 to 40 mmHg in the first (1.12 Ϯ 0.08 vs. 0.80 Ϯ 0.02%/mmHg, P ϭ 0.001) and the fifth (1.76 Ϯ 0.31 vs. 1.05 Ϯ 0.06%/mmHg, P ϭ 0.024) hypoxic bouts. Repetitive IH exposures attenuated (P ϭ 0.049) the tachycardiac response to hypoxia while significantly enhancing normoxic R-R interval variability in low-frequency and high-frequency spectra without changes in arterial blood pressure at rest or during hypoxia. We conclude that 14-day IH exposures enhance arterial O 2 delivery and improve vagal control of HR during hypoxic hypoxemia.
CYCLIC INTERMITTENT HYPOXIA (IH) has been extensively applied as a transient acute hypoxemia to challenge cardiovascular and respiratory function, and to induce physiological acclimatization (4, 46) . Because both detrimental (2, 38, 39) and beneficial (6, 31, 32, 56) effects of IH have been reported, it is important to further understand respiratory and cardiovascular adaptations to repetitive low-dose IH exposures. During hypoxia, the most apparent cardiorespiratory responses are hyperventilation (13) and tachycardia (43) . These responses are essential to sustain tissue oxygen delivery in the face of systemic hypoxic hypoxemia. However, the hypoxia-stimulated ventilatory response causes respiratory alkalosis (27, 50) , which shifts the oxyhemoglobin equilibrium response, i.e., the distribution of O 2 between hemoglobin-bound O 2 , as reflected by arterial O 2 saturation (Sa O2 ), and dissolved O 2 , as reflected by partial pressure of arterial O 2 , toward the left (55) . In addition, we previously observed that acute cyclic hypoxic exposures caused a decrease in oxygen-hemoglobin affinity, as indicated by a steeper slope of Sa O2 to partial pressure of end-tidal O 2 (PET O2 ), an index of arterial PO 2 (55) . The question remained as to whether this oxyhemoglobin equilibrium response would be maintained or enhanced following repetitive cyclic IH exposures.
Although acute hypoxic hypoxemia stimulates a tachycardiac response (55) , it has been reported that the arterial baroreflex-mediated heart rate (HR) response is not altered during acute hypoxic exposure (18, 19) or after repetitive hypoxic exposures (14) . Because arterial blood pressure (ABP) remains relatively constant during poikilocapnic IH exposures (1, 37, 55) , probably resulting from a counterbalance between hypoxia-induced peripheral vasodilation (7, 9) and sympathetic activation (20, 52) during the hypoxic challenge, we postulated that arterial baroreceptors are considerably less responsive than arterial chemoreceptors during repetitive IH exposures. However, following 14-day IH exposures, Bernardi et al. (3) observed a diminished tachycardiac response to chemostimulation by a combination of hypercapnia with hypoxia during closed-circuit rebreathing. Because cyclic hypoxic exposures rapidly reset the tachycardiac response to poikilocapnic hypoxia (55) and significantly enhance vagal-cardiac influence (3), these previous observations suggested that the chemoreceptors are highly plastic in response to hypoxic stimulus (40, 41) . However, it remained unknown whether repetitive low-dose IH exposures would alter the hypoxia-stimulated chemoreflex control of tachycardia response to acute cyclic hypoxic hypoxemia.
The purpose of the present study was to examine the differences in oxyhemoglobin equilibrium and tachycardiac responses to acute cyclic hypoxic hypoxemia before and after acclimatization to repetitive IH exposures for 14 days. This IH protocol was adopted because it was previously shown that the IH dose or duration was safe and produced adaptive responses in humans (3, 30) and in animals (31, 32, 56) . We hypothesized that the oxyhemoglobin equilibrium response would be enhanced to promote tissue oxygenation and that the magnitude of the tachycardiac response to hypoxia would be diminished as a result of acclimatization to chronic IH exposures.
METHODS
Participants. Eight healthy nonsmokers (5 men and 3 women, 24.8 Ϯ 1.2 yr old, 24.1 Ϯ 1.1 kg/m body mass index) voluntarily participated in the study. All volunteer subjects signed an informed consent that was approved by the Institutional Review Board. The study protocol was reviewed and approved by the Institutional Review Board and the Office for the Protection of Human Subjects at the University of North Texas Health Science Center. All subjects underwent and passed a graded exercise stress test on a cycle ergometer (SCIFIT, Tulsa, OK) and were confirmed to be free of cardiovascular or pulmonary diseases. No subject had previously participated in a hypoxia study or lived in an area Ն3,000 feet above sea level. Before the experiment, all subjects were familiarized with the experimental procedures and measurements of the study.
Cyclic hypoxic exposures. Normobaric-poikilocapnic IH exposures were induced with inhalation of medical gas with 10.0 Ϯ 0.2% O 2 (balance nitrogen) for 5-6 min interspersed with 4 min inhalation of room air, repeated 5-10 times for 14 days ( Table 1 ). The cumulative duration of repetitive IH exposures in the present study was 11 h and 49 min in 14 sessions (or days). One subject completed the same hypoxic time (709 min 14-day IH exposures) in 16 days due to skipping Sundays. No subjects experienced discomfort during the hypoxic exposures.
Measurements. All measurements were made with the subject in the supine position and wearing a disposable face mask (VacuMed, Ventura, CA). During the experiment, the subject's HR was monitored from an electrocardiogram (BIOPAC, Santa Barbara, CA). Systolic and diastolic blood pressures (SBP and DBP, respectively) were measured by a brachial arterial cuff inflated/deflated automatically using Tonometry (Colin Model 7000; Tonometry, San Antonio, TX). Systemic Sa O2 and partial pressure of transcutaneous CO2 (PTCCO2) were measured by a sensor (TOSCA 500; Radiometer America, Westlake, OH) placed on the subject's earlobe. Breath-bybreath PET O2 and partial pressure of end-tidal CO2 (PETCO2) were continuously monitored by a mass spectrometer (1100 Medical Gas Analyzer; Perkin-Elmer, St. Louis, MO), which would be considered as proxies of arterial PO 2 and PCO2, respectively, in the present study. Breathing frequency (fB) and tidal volume (VT) were measured by a Universal Ventilation Meter (UMV VacuMed). Analog data were continuously digitized at 250 Hz by a computer interfaced with a BIOPAC MP150 data acquisition system. Study protocol. The study focus was to compare the difference in oxyhemoglobin equilibrium and HR responses to acute cyclic hypoxic hypoxemia during the first and fifth hypoxic bouts between day 1 and day 14 IH exposures ( Fig. 1) . After resting supine for Ն20 min, baseline R-R intervals (RRI), HR, Sa O2, PETO2, PETCO2, PTCTCCO2, VT, and fB were recorded continuously for ϳ5 min. SBP and DBP were read from a brachial arterial cuff one time every ϳ75-90 s at baseline and throughout IH exposures. Each hypoxic exposure was followed by a 4-min recovery with inhalation of room air (Fig. 1 ).
Intermittent inhalations of room air or hypoxic gas were controlled by a Rudolph three-way directional stopcock. Data collected during day 1 of the hypoxic procedure have been partially reported previously (55) .
Data analyses. Baseline normoxic data were averaged over 1 min before the first and fifth hypoxic bouts. Five-minute steady-state RRI before day 1 and day 14 hypoxic exposures were analyzed using power spectral analysis (Welch option) after fast-Fourier transform with the data analysis and display program (DADiSP, Cambridge, MA) as previously described (11, 17, 54) . Low-frequency power between 0.04 and 0.14 Hz and high-frequency power between 0.15 and 0.40 Hz of RRI variability were extracted and compared between day 1 and day 14. During hypoxic exposures, the last 30-s continuous data of each minute from the first and fifth bouts were averaged. The response of HR to decrease in PET O2 during hypoxic hypoxemia was analyzed by linear regression. Analysis of covariance using a general linear model procedure was applied to test for the difference in slopes during the first and fifth hypoxic bouts between day 1 and day 14.
Responses of Sa O2 to decreases in PETO2 during hypoxic hypoxemia were fitted with a three-parameter sigmoid model:
where parameter A is maximal SaO2, parameter B is a coefficient, and parameter C is PETO2 at the maximum gain of O2 dissociation. Nonlinear regression procedure was applied to extrapolate the values of PET O2 at 50% of SaO2 (P50) and to "interpolate" the values of SaO2 associated with 45 mmHg PETO2. Both of these variables were compared as indications of the directional shift in the oxyhemoglobin equilibrium response during the first and fifth hypoxic bouts between day 1 and day 14. Furthermore, for each PET O2 during hypoxic bouts, the rates of decreases in SaO2, i.e., gains of deoxygenation (or the slope of ⌬SaO2/⌬PETO2), were derived with nonlinear regression from the equation:
Mean gains computed for respective hypoxic bouts were averaged within the range of decreases in PETO2 from 65 to 40 mmHg and compared during the first and fifth hypoxic bouts and between day 1 and day 14, respectively. This PET O2 range was selected because, within this moderate hypoxemia during IH exposures, there is a free fall of Sa O2 associated with unit drop of PETO2 (which is the focus of the DISCUSSION), and because beyond Ն65 mmHg there is no substantial change in Sa O2 associated with change in PETO2 according to the data observed in the present study and/or conventional belief in the field. Data that passed the Shapiro-Wilks (W statistic) for normality test were subjected to three-factor ANOVA applied to test the significance of hypoxic time (factor I), bout (factor II), and day (factor III) effects on the variables. Post hoc analysis with Turkey's option was applied if the main factor showed significance. Only V T did not pass the normality test, so the Wilcoxon Scores (rank sums) nonparametric ANOVA was used for these data. Statistical analyses were performed using the software program Statistical Analysis System (version 9.1; SAS, Cary, NC). All data are reported as group means and SE of the mean. Significance level was set at P Յ 0.05.
RESULTS
Baseline normoxic data. Acute cyclic hypoxic exposures significantly decreased baseline PET O2 and Sa O2 before the fifth hypoxic bout compared with those variables before the first hypoxic exposures (Table 2) . On day 14, baseline HR before either the first or fifth hypoxic bout was significantly lower compared with that on day 1 (Table 2 ), but there was no significant difference in baseline ABP (Table 3) . Because the baseline PET CO2 or PTC TCCO2 , V T , and f B before the first hypoxic exposure were statistically identical between day 1 and day 14, arterial pH at rest should not be significantly altered by repetitive IH exposures. Two weeks of IH exposures significantly increased baseline RRI variability in both lowfrequency (0.04 -0.14 Hz) and high-frequency (0.15-0.40 Hz) power spectra, i.e., day 1 vs. day 14: 393 Ϯ 128 vs. 899 Ϯ 235 ms 2 (P ϭ 0.020) and 622 Ϯ 193 vs. 1,071 Ϯ 247 ms 2 (P ϭ 0.014) for low frequencies and high frequencies, respectively (Fig. 2) .
Ventilation during hypoxia. Hypoxic exposures increased V T , f B , and minute ventilation (Table 4) . These variables plateaued in 3-4 min during hypoxic bouts on both day 1 and day 14. Normobaric-poikilocapnic hypoxia did not cause a progressive hyperventilation linearly associated with hypoxic time as decreases in Sa O2 or increases in HR. This discrepancy in hyperventilation was probably due to a counteraction between the hypoxia-stimulated ventilatory response and the hyperventilation-evoked hypocapnia and respiratory alkalosis during poikilocapnic hypoxic exposures. However, f B and ventilation were significantly less during the first minute of hypoxic exposure on day 14 than on day 1 (Table 4) . PET CO2 and PTC TCCO2 decreased during hypoxia on both day 1 and day Data are group means Ϯ SE; n ϭ 8 experiments. HR, heart rate; SaO2, arterial O2 saturation; PETO2, partial pressure of end-tidal O2; PETCO2, partial pressure of end-tidal CO2; PTCCO2, partial pressure of transcutaneous CO2; VT, tidal volume; fB, breathing frequency; V E, minute ventilation. * And † denote a significant difference between day 1 and day 14, and between the 1st bout and the 5th bout within the day, respectively, according to post hoc analysis. Baseline data for the 5th bout is the last minute room-air inhalation recovery from the previous hypoxic bout.
14. Both PET CO2 and PTC TCCO2 were persistently greater on day 14 than on day 1, suggesting that the acute respiratory alkalosis evoked by hypoxia-stimulated hyperventilation was attenuated following 14-day IH exposures (Table 4) .
Sa O2 during hypoxia. During poikilocapnic hypoxic exposures, Sa O2 and PET O2 progressively decreased. The upper portion of the Sa O2 /PET O2 curves (i.e., the early time of hypoxic exposure) during the fifth hypoxic bout was shifted leftward compared with the first hypoxic bout on both day 1 and day 14 (Fig. 3, top) . This transient leftward shift during repeated cyclic hypoxic bouts was likely the result of acute respiratory alkalosis during hypoxia-stimulated hyperventilation. However, at lower PET O2 (i.e., during the final minutes of the hypoxic exposures), the Sa O2 /PET O2 curves of the fifth hypoxic bout crossed over to the right side of the first hypoxic bout curves, probably due to the accumulation of 2,3-diphosphoglycerate (2,3-DPG) produced by red blood cells during repeated cyclic hypoxic bouts, which could occur within minutes (26) . This effect of cumulating 2,3-DPG would have changed the conformation of hemoglobin, reduced its oxygen affinity (21) , and counterbalanced the repeated hypoxia-induced respiratory alkalosis (28) during acute cyclic IH exposures. As a result, the values of P50 tended to be greater during the fifth than the first hypoxic bout: 31.4 Ϯ 1.5 vs. 28.2 Ϯ 1.3 mmHg (P ϭ 0.099) on day 1 and 39.4 Ϯ 2.4 vs. 33.9 Ϯ 1.5 mmHg (P ϭ 0.052) on day 14. The deoxygenation gains (i.e., the rate of ⌬Sa O2 /⌬PET O2 ) associated with decreases in PET O2 from 65 to 40 mmHg (Fig. 4, top) were greater in the fifth than in the first hypoxic bouts on both day 1 (1.05 Ϯ 0.6 vs. 0.80 Ϯ 0.02%/mmHg, P ϭ 0.001) and day 14 (1.76 Ϯ 0.31 vs. 1.12 Ϯ 0.08%/mmHg, P ϭ 0.048). However, the values of Sa O2 associated with PET O2 at 45 mmHg during the first vs. fifth hypoxic bout were not significantly different on day 1 (81.4 Ϯ 0.2 vs. 79.9 Ϯ 1.5%, P ϭ 0.345) and only marginally different on day 14 (75.8 Ϯ 0.7 vs. 72.4 Ϯ 1.8%, P ϭ 0.085).
Compared with day 1, the relationships of Sa O2 /PET O2 for both the first and fifth hypoxic bouts were significantly shifted rightward following 14-day IH exposures (Fig. 3, bottom) . Thus, the values of P50 were significantly greater on day 14 than on day 1, i.e., 33.9 Ϯ 1.5 vs. 28.2 Ϯ 1.3 mmHg (P ϭ 0.005) during the first hypoxic bouts and 39.4 Ϯ 2.4 vs. 31.4 Ϯ 1.5 mmHg (P ϭ 0.006) during the fifth hypoxic bouts. The deoxygenation gains associated with decreases in PET O2 from 65 to 40 mmHg (Fig. 4, bottom) were significantly greater on day 14 than day 1 during both the first (1.12 Ϯ 0.08 vs. 0.80 Ϯ 0.02%/mmHg, P ϭ 0.001) and fifth (1.76 Ϯ 0.31 vs. 1.05 Ϯ 0.06%/mmHg, P ϭ 0.024) hypoxic bouts. Furthermore, the values of Sa O2 associated with PET O2 at 45 mmHg were significantly less on day 14 than day 1, i.e., 75.8 Ϯ 0.7 vs. 81.4 Ϯ 0.2% (P Ͻ 0.001) during the first and 72.4 Ϯ 1.8 vs. 79.9 Ϯ 1.6% (P ϭ 0.002) during the fifth hypoxic bouts. Overall, PET O2 during hypoxic exposures was persistently (P Ͻ 0.001) higher on day 14 than on day 1 (Table 4 and Fig. 3,  bottom) , indicating an improved systemic arterial oxygenation during the moderate hypoxemia.
HR during hypoxia. Although ABP was not significantly changed by normobaric-poikilocapnic hypoxia (Table 3) , HR was significantly increased during cyclic hypoxia (Fig. 5) . Acute cyclic hypoxic exposures rapidly augmented the magnitude of this tachycardiac response (P ϭ 0.001) as indicated by the slopes of HR/PET O2 . These slopes were greater Table 3 . Arterial blood pressure during cyclic IH exposures for the fifth bout than for the first bout on day 1 (Ϫ1.46 Ϯ 0.06 vs. Ϫ0.46 Ϯ 0.04 beats·min Ϫ1 ·mmHg Ϫ1 , P Ͻ 0.001) and on day 14 (Ϫ1.14 Ϯ 0.16 vs. Ϫ0.40 Ϯ 0.06 beats·min Ϫ1 ·mmHg Ϫ1 , P ϭ 0.001). Two-week repetitive IH exposures significantly attenuated the rate of tachycardiac responses, and the slopes of HR/PET O2 were consistently less (P ϭ 0.049) on day 14 than on day 1 (Fig. 5) . However, there was no significant difference in the slopes of HR/PET O2 between day 1 and day 14 after stratification for the bout factor. Overall, HR during hypoxic exposures was signifiLow-frequency 0.04 -0.14 Hz Hypoxic time: P Ͻ 0.001; Bout factor: P Ͻ 0.001; Day factor: P Ͻ 0.001
Data are group means Ϯ SE; n ϭ 8 experiments. Three-way ANOVA is applied to determine the significance of the main factors, i.e., hypoxic time, different bouts and days. P value reports the outcome of 3-way ANOVA excluding the baseline (i.e., room air) data. * and † denote a significant difference between day 1 and day 14 within the same bout, and between the 1st bout and the 5th bout within the same day, respectively. Note: the duration or time of hypoxic exposures is increased from 5 min on day 1 to 6 min on day 14. Thus, there is no the 6th min data on day 1. cantly lower on day 14 than day 1, indicating an improved cardiac function.
DISCUSSION
The present study has demonstrated two new findings. First, 14-day normobaric-poikilocapnic IH exposures shift the oxyhemoglobin equilibrium response rightward and enhance tissue O 2 delivery during progressive hypoxic hypoxemia. Second, repetitive normobaric-poikilocapnic IH exposures enhance baseline vagal-cardiac function and attenuate tachycardiac response to hypoxia without significant influence on baseline ABP or the response of ABP to hypoxia. These findings should be helpful in understanding disparate reports of responses to repetitive low-dose IH and in planning future IH studies.
Oxyhemoglobin equilibrium response. Respiratory alkalosis resulting from hypoxia-stimulated hyperventilation shifts the oxyhemoglobin equilibrium response leftward. The present study confirmed that the relationship between changes in Sa O2 and PET O2 , as an indication of the oxyhemoglobin equilibrium response, showed a leftward shift in the upper portion of the Sa O2 /PET O2 curves during the fifth hypoxic bout on both day 1 and day 14 (Fig. 3, top) . On the other hand, the lower portion of the Sa O2 /PET O2 curves during the fifth hypoxic bout moved rightward across the curves during the first hypoxic bout, indicating an increased P50 despite the persistent respiratory alkalosis during repeated cyclic hypoxic bouts. This dynamic interaction of the oxyhemoglobin equilibrium response with cyclic bouts of acute IH exposures on both day 1 and day 14 likely resulted from the counterbalance between repeated hypoxia-induced acute respiratory alkalosis and accumulation of 2,3-DPG induced by intracellular hypoxia of red blood cells during cyclic hypoxemia, which could take place very rapidly (26) . The rightward shift of the oxyhemoglobin equilibrium response at low PET O2 would accelerate arterial O 2 delivery to tissue and appears to be an important adaptation to repeated bouts of IH. Interestingly, this effect was greater on day 14 compared with day 1 as shown during both the first and fifth hypoxic bouts (Fig. 3, bottom) .
One possible mechanism for the rightward shift of the oxyhemoglobin equilibrium response to hypoxic hypoxemia following 14-day IH exposures (Fig. 3, bottom) could be an acclimatization-enhanced arterial buffer capacity against acute respiratory alkalosis. Earlier studies suggested that compensatory changes for respiratory alkalosis elicited by hypoxiastimulated hyperventilation are mobilized promptly (33, 47) and take place in both blood and cerebrospinal fluid (10, 12) . As a result of repetitive IH exposures, the repeated cyclic mobilization of these compensatory changes could become more efficient and efficacious to buffer respiratory alkalosis. A consistently greater PET CO2 and PTC TCCO2 during hypoxic exposures on day 14 than on day 1 (Table 4) supports the notion that arterial blood pH was less alkalized by hypoxia-stimulated hyperventilation following 14-day repetitive IH exposures. These less reduced PET CO2 and PTC TCCO2 values (Table 4) would produce the effect that caused the greater rightward shift in oxyhemoglobin equilibrium response during hypoxic hypoxemia following 14-day IH exposures. Another plausible mechanism for the rightward shifted oxyhemoglobin equilibrium response could be related to an increased hemoglobinnitric oxide (NO) complex during hypoxic bouts following repetitive IH exposures. NO binds rapidly to hemoglobin (23, 53) , and it has been proposed that hemoglobin concurrently Table 2 ). Top: acute responses to cyclic hypoxia on day 1 (top left) and on day 14 (top right). During the 5th hypoxic bout on each day, the upper portion of the SaO2/PETO2 curve is shifted leftward. However, the lower portion of the curve tends to merge (top left) or to overtake (top right) the curve during the 1st hypoxic bout, and the values of PETO2 at 50% of SaO2 (P50) tend to be greater in the 5th than 1st hypoxic bouts. Bottom: adaptive responses to 14 days of repetitive hypoxic exposures. The relationship of SaO2 as a function of PETO2 is significantly shifted to the right for both the 1st (bottom left) and 5th (bottom right) hypoxic bouts on day 14. In addition, the slopes of SaO2/PETO2 during both the 1st and 5th hypoxic bouts become steeper, indicating a greater decrease in SaO2 per unit decrease in PETO2 during hypoxemia following 14-day repetitive IH exposures.
acts as both a hypoxic sensor (8, 23, 34) and a NO carrier (16, 35) to couple hypoxia to NO-mediated vasodilation to adjust tissue oxygen delivery (9, 48, 51) . This hypoxia-promoted intramolecular transfer of NO within hemoglobin (23) would allosterically alter the conformation of O 2 -carrier proteins (22) and alter O 2 -hemoglobin affinity, which might be enhanced during acute cyclic hypoxic bouts by repetitive IH exposures. This change may be related to the increased gains of deoxygenation associated with decreases in PET O2 during acute cyclic hypoxic bouts and following repetitive 14-day IH exposures (Fig. 4) . HR response. ABP was maintained at normal, baseline level during the entire duration of normobaric-poikilocapnic IH exposures (Table 3) . These data were consistent with previous observations (1, 36, 37 ) that acute hypoxia with poikilocapnia or isocapnia did not cause a hypertensive response in healthy young adults. An increase in sympathetic nerve activity during hypoxia may, thus, be counterbalanced by a hypoxia-mediated vasodilatory mechanism. However, there was a progressive tachycardiac response correlated with continuous decreases in PET O2 during hypoxia (Fig. 5) . This progressive increase in HR was not correlated with the mechanic mechanism of the hyperventilation since the augmented ventilation plateaued during hypoxia as counteracted by the hyperventilation-induced respiratory alkalosis or hypocapnia. Thus, this tachycardiac response to decreases in PET O2 was predominantly stimulated by a hypoxia-induced chemoreflex. Because ABP did not fall during poikilocapnic hypoxic exposures, arterial baroreceptor activity was minimally affected. The chemoreflex-stimulated tachycardiac response during hypoxia would help increase cardiac output and sustain flow-mediated O 2 delivery to tissues.
The present data confirmed that acute cyclic hypoxic exposures caused a rapid reset of the tachycardiac responses on both day 1 and day 14 (55) . This significantly sensitized chemoreflex-mediated tachycardia was manifested by the greater magnitude of HR increases driven by decreases in PET O2 . This promptly augmented chemoreflex control of HR response could be related to greater decreases in systemic or arterial PO 2 ( Table 2 ) during repeated cyclic hypoxic bouts (Table 4) . However, the overall HR and the magnitude of tachycardiac responses during the first and fifth hypoxic bouts were significantly smaller following 14-day repetitive IH exposures ( Fig.  5) , indicating an effect of IH conditioning.
Because the hypoxia-stimulated hyperventilation during poikilocapnic IH exposures (Table 4) was not significantly different for day 1 and day 14, this altered tachycardiac response was unlikely explained by a change in the sensitivity of peripheral chemoreceptors. We postulated that IH conditioning-enhanced parasympathetic nerve activity (3) could be the mechanism responsible for the diminished tachycardia in response to decreases in PET O2 during hypoxic hypoxemia observed in the current study. This appeared to be supported by data showing that the baseline HR was lower (Table 2 ) and the baseline RRI variability in both low-frequency and high-frequency spectra was significantly enhanced following 14-day IH exposures (Fig. 2) . This improved vagal-cardiac function, which appears to be similar as a common adaptation associated with physical exercise training (49), may partially explain the cardiac protection against ischemia and arrhythmia observed in dogs (31, 56) and in rats (6, 32) following chronic IH conditioning.
Technique considerations and limitations of the study. Normobaric-poikilocapnic hypoxia with 10% of inspired O 2 for 6 min does not cause a severe hypoxemia, i.e., arterial PO 2 Յ35 mmHg, which could be detrimental for induction of irreversible damage to cells or organs. The present study indicates that exposure to 10% O 2 normobaric-poikilocapnic hypoxia for 6 min is a safe dose. Hypoxic hypoxemia during the exposures to 10% O 2 causes progressive decreases in Sa O2 and PET O2 without a plateau within 6 min. However, poikilocapnic hypoxia does not cause a progressive hyperventilation or adaptation as seen during isocapnic hypoxia (25, 29, 42) because poikilocapnic hypoxia-stimulated ventilatory response is counteracted by hyperventilation-elicited hypocapnia or respiratory alkalosis. Therefore, neither Sa O2 (nor PET O2 ) nor hypoxic time (in min) can predict the increases in minute ventilation due to the hypocapnia-mediated compensation (which can inhibit central and peripheral chemoreceptors). This may be a mechanism why low-dose poikilocapnic hypoxia-induced moderate hypoxemia, i.e., PO 2 between 36 and 60 mmHg, differs from obstructive sleep apnea, which causes not only hypoxemia but also acute hypercapnia and respiratory acidosis. This combination of prolonged hypoxemia and respiratory acidosis may inflict a stronger impact on cardiovascular and respiratory functions.
The main limitation in the present study is that the changes in arterial PO 2 were estimated from the changes in PET O2 . However, we believe the faith-based predication that breathby-breath continuously measured PET O2 was faithfully related to changes in alveolar and arterial PO 2 in healthy young subjects who have no cardiovascular or respiratory problems. Therefore, PET O2 was considered to be a reliable proxy of alveolar or arterial PO 2 in the present study. Because all subjects in the present study were young healthy nonsmokers, this study implication may not extend to other age groups or subjects with pathological conditions. Furthermore, we did not have the data on menstrual cycle of three women within the group, so the group data could have been randomly affected by the presence or absence of ovarian hormones. Another limitation is that we did not measure hemoglobin concentration, which might have been altered by IH and, thus, might have affected the oxygen saturation data. Previous studies reported that three weeks of hypobaric IH exposures significantly increased hemoglobin concentration in young subjects (45) along with improved aerobic capacity (44) . However, in patients with mild chronic obstructive pulmonary disease, three weeks of normobaric IH did not change hemoglobin concentration, although total hemoglobin content was increased due to a significant expansion of blood volume (5). Gore et al. (15) reported that neither hemoglobin concentration nor hemoglobin content was significantly altered in highly fit young subjects following 4 wk normobaric (24) or hypobaric (15) IH. Considering that our young subjects were exposed to shortduration low-dose IH for only two weeks, it seems likely that any increases in hemoglobin would have been minimal and would not have significantly impacted the findings of this investigation.
Perspectives and Significance
Adaptive adjustments or regulations of oxyhemoglobin equilibrium and cardiac responses can take place very rapidly (within minutes) during acute normobaric-poikilocapnic IH exposures. Acute cyclic hypoxic bouts caused an initial leftward shift followed by a rightward shift in oxyhemoglobin equilibrium response on both day 1 and day 14, likely resulting from counterbalanced interaction between repeated acute respiratory alkalosis and cumulative production of 2,3-DPG associated with cyclic hypoxemia. This rightward shift at low PET O2 was associated with both the increased values of P50 and the augmented gains of deoxygenation (i.e., the rate of ⌬Sa O2 / ⌬PET O2 ), which would rapidly compensate for the hyperventilation-induced respiratory alkalosis and promoted O 2 delivery during acute cyclic hypoxemia. Repetitive normobaric-poikilocapnic IH exposures for 14 days enhanced this acute interaction. This acclimatization would be physiologically significant by counteracting the effect of hyperventilation-induced acute respiratory alkalosis and thus improving tissue O 2 delivery during hypoxic challenge. Although ABPs of young healthy subjects were not significantly changed by normobaricpoikilocapnic IH exposures, IH conditioning significantly enhanced vagal-cardiac function and attenuated the chemoreflexstimulated tachycardiac response during hypoxic hypoxemia. Table 2 ). On day 1 or day 14, the slope of the relationship of HR to PETO2 is steeper for the 5th bout (P ϭ 0.001). This significant difference in the slopes remained after stratification for the day factor, i.e., there is significant interaction of PETO2 with bout factor for the increase in HR during hypoxia (P Ͻ 0.001 for day 1 and P ϭ 0.001 for day 14) . Following 14-day repetitive IH exposures, the slopes of tachycardiac responses per unit hypoxia (decrease in partial pressure of end-tidal O2) are diminished (P ϭ 0.049) on day 14 compared with on day 1. There is no significant interaction of PETO2 with the day factor for tachycardiac response (P ϭ 0.470 for the 1st bout and P ϭ 0.117 for the 5th bout) after stratification for the bout factor, although the overall increases in HR are persistently smaller (P ϭ 0.001) during hypoxic exposures on day 14. time 60 min/day or session for 14 days) has cross-protective conditioning values to confer better cardiorespiratory preparation against hypoxic challenge.
In conclusion, 14-day normobaric-poikilocapnic IH conditioning can be safely and effectively applied to enhance oxyhemoglobin equilibrium and cardiac responses during hypoxic hypoxemia.
